1. Introduction
The term “endocrine-disrupting chemical” (EDC) has been defined as “an exogenous substance or a mixture that alters function(s) of the endocrine system and consequently causes adverse health effects in an intact organism, or its progeny, or (sub)populations” [1]. Several studies have found that the endocrine system of exposed individuals may be disrupted by EDCs, and exposure can also have an impact on human reproduction and development [2,3,4,5]. EDCs can interfere with the normal functions of endogenous hormones by changing hormone levels, blocking or boosting hormone production, or modifying hormone transport across the body, thereby disrupting hormonal control [4]. Exposure to EDCs in humans can occur via absorption through the skin, inhalation in the air, or ingestion of contaminated food and water. However, human exposure to EDCs occurs most frequently when contaminated food is consumed. Bisphenol A (BPA), phthalates, parabens, nonylphenols, and heavy metals are the EDCs most frequently found in contaminated food. In male reproductive health, EDCs have been associated with alternations in fetal development, such as hypospadias and cryptorchidism, as well as lower semen quality, resulting in male infertility. In addition, development of testicular germ-cell, prostate, and breast cancers has been observed in relation to EDCs [4,5,6].
In almost half of infertile couples, the male factor is the sole or secondary cause of infertility [7]. Numerous endocrine disruptors (EDs) have been researched for their effects on male fertility, including phthalates, polychlorinated biphenyls, dioxins, pesticides, and parabens [8,9]. According to epidemiological data, the rise in EDCs in the environment over the past 50 years has been linked to an increase in male reproductive tissues. These chemicals have been linked to a decline in semen quality and direct effects on spermatozoa, such as changes in motility, viability, and acrosomal reaction due to the generation of oxidative stress. Additionally, EDCs have been suggested as a potential factor in testicular dysgenesis syndrome [10].
Phthalates are among the many environmental chemicals and xenobiotics that have been found to cause oxidative stress, which may affect the endocrine system and result in reproductive anomalies. Oxidative stress is related to free radicals, such as reactive oxygen species (ROS), which are produced either via endogenous processes such as normal cellular metabolism, or by external factors such as radiation, chemicals, and hyperoxia. Numerous studies show that ROS are a double-edged sword: they can play a crucial signaling role in physiological processes, while also playing a role in pathological processes. The capacity of the endogenous cellular antioxidant defense system is severely overwhelmed when ROS are present at higher levels, leading to oxidative stress [11,12].
Uncontrolled ROS generation may be damaging to cells and other biomolecules, including amino acids, proteins, carbohydrates, lipids, and deoxyribonucleic acid (DNA), which can all be destroyed. ROS can have a detrimental effect on sperm function and quality [13,14,15,16] due to the spermatozoa’s decreased motility [17], DNA damage [18,19,20], and the compromised integrity of the cellular membrane [15,21,22].
1.1. Bisphenol A (BPA)
Bisphenols (BPs) are a significant class of EDCs. The most well-known and possibly most extensively researched bisphenol is called bisphenol A (BPA). For more than 50 years, BPA, 4,40-isopropylidenodi-phenol, 2,2-bis(4-hydroxyphenylo)propane—a crystalline chemical compound—has been widely used as a key monomer of epoxy resins and polycarbonate (PC) plastics. BPA-based PC plastics have achieved widespread success thanks to their resilience, flexibility, and durability. As a result, they are used in a wide range of industries, from the arms industry to make safety equipment (e.g., helmets), to the production of medical devices such as dental sealants and fillers [23,24,25,26]. Years ago, it was established that even plastic baby bottles contain BPA [27]. According to the major regulatory agencies, dietary exposure to BPA is the main way that people are exposed to it. A tolerable daily intake (TDI) of 50 μg/kg body weight/day has been established based on studies using rodent models, where harmful effects were clearly seen at much higher doses [24,28,29,30,31,32,33,34].
Preclinical research findings have shown the endocrine-disrupting effects of BPA on male reproductive functions, elucidating potential pathways by which BPA can interfere with the control of spermatogenesis—primarily through the hypothalamic–pituitary–gonadal axis [35]. The three primary BPA substitutes—bisphenol F (BPF), bisphenol S (BPS), and bisphenol AF (BPAF)—share homologies with BPA in terms of chemical structure, but have received far less research than BPA. However, the widespread use of BPs has made them problematic for the environment and human health. Harmful effects of BPs on humans are receiving increasing attention, but studies on their reproductive toxicity are still limited. The study of Gao et al., revealed that BPs disturbed germ cell proliferation, induced germ cell apoptosis, and perturbed sperm functions and spermatogenesis, as a result of the disruption of testosterone biosynthesis in Leydig cells [36].
1.2. Phthalates
Phthalates are one of the classes of environmental EDs that are used as plasticizers for polyvinyl chloride plastics to increase the flexibility, durability, and longevity of the plastics. Phthalates include monoethyl phthalate (MEP), dimethyl phthalate (DMP), mono-2-ethylhexyl phthalate (MEHP), di-2-ethylhexyl phthalate (DEHP), diisobutyl phthalate (DIBP), monobenzyl phthalate (MBzP), mono-n-butyl phthalate (MnBP), mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono-n-octyl phthalate (MnOP), monoisononyl phthalate (MiNP) and mono-2-ethyl-5-carboxypentyl phthalate (MECPP). Numerous individuals are potentially exposed to these chemicals due to widespread use of plastic products in daily life, in addition to thousands of individuals employed in the production of plastic and plastic products, as well as the recycling of plastic [37]. Although phthalates are quickly metabolized and eliminated, their widespread use ensures ongoing exposure from conception to adulthood, as shown by numerous human biomonitoring studies conducted around the world [38]. In general, urban men were found to have much higher levels of phthalate esters in their semen than rural men. Additionally, phthalates were found in semen at statistically higher amounts in infertile men than in fertile males [39,40,41].
1.3. Parabens
Ethyl paraben (EP), butyl paraben (BP), methyl paraben (MP), propyl paraben (PP), and isobutyl paraben (iBuP) are examples of the class of preservatives known as parabens that are frequently employed in cosmetic and medicinal products [42]. They are a group of parahydroxybenzoates or esters of parahydroxybenzoic acid—also called 4-hydroxybenzoic acid—according to their chemical makeup. Because of their bactericidal and fungicidal properties, they are widely used. They can be found in commonly used personal care items such as toothpaste, shampoos, shower gels, moisturizers, lubricants, makeup, and topical and parenteral pharmaceuticals. Additionally, they are frequently utilized as food preservatives, making it challenging to avoid them. In several in vitro and in vivo studies, parabens have been linked to weak estrogenic and anti-androgenic actions [43]. It was found that the percentage of spermatozoa with abnormal morphology and high DNA damage was significantly increased with increasing urinary paraben concentrations, while the percentage of motile spermatozoa and male testosterone levels decreased [42]. Additionally, a positive association was discovered between urine levels of BP and sperm XY18 disomy, and between urinary PP levels and chromosome 13 disomy, in men attending infertility clinics [44].
1.4. Mode of Action of EDCs
It is difficult to assess how different EDCs affect semen quality, and how this affects male fertility, because they might have an impact alone, in groups, or in conjunction with other harmful environmental agents [44,45,46]. In addition, the examination of EDCs’ impact on health is further complicated by the fact that there are also numerous metabolites of EDCs. At any point in their life, men are susceptible to exposure to these hazardous environmental agents. Prenatal, in utero exposure to these substances is quite concerning because it may have detrimental effect on adult health, including decreased reproductive function.
According to Axelsson et al., males in the highest prenatal exposure tertile to a single diisononyl phthalate (DiNP) metabolite (mono-(carboxy-iso-octyl) phthalate) had 4.3 mL smaller total testicular volume, 30% higher levels of serum follicle-stimulating hormone (FSH), and 0.87 mL lower semen volumes than men in the lowest tertile [46]. Men in the highest prenatal exposure tertile to one diethylhexyl phthalate (DEHP) metabolite (mono-(2-ethyl-5-hydroxylhexyl) phthalate) had 0.70 mL lower semen volume than men in the lowest exposure tertile. Mono-(hydroxy-iso-nonyl) phthalate and mono-(oxo-iso-nonyl) phthalate—two DiNP metabolites—had a linear correlation with serum luteinizing hormone (LH) levels. All of these changes could be related to the deterioration of male reproductive function.
Moreover, prenatal exposure to all EDCs is linked to a higher risk of hypospadias and cryptorchidism in newborns, as well as a lower sperm quality and a higher risk of testicular cancer in young adult males [47,48,49]. The most significant impacts of EDCs are unquestionably those that directly influence human spermatozoa, since they have an impact on how well they can fertilize human oocytes and how the embryo develops [41]. In addition, they can also affect the offspring or even subsequent generations [46,47,48,49]. Most of these direct effects are the consequence of oxidative stress. One of the signs of oxidative stress, among others, is DNA damage.
The purpose of this article was to review the literature and summarize the knowledge about the association of EDCs with human sperm quality and male fertility.
2. Methods
We conducted an electronic search using PubMed for studies on EDs related to oxidative stress and male infertility. The following medical subject heading (MeSH) terms, keywords, and their combinations were used: “endocrine disruptors” AND “oxidative stress” AND “male infertility”. The search was limited to trials in humans and published in the English language in the past 20 years up to May 2022.
The inclusion criteria included cross-sectional studies, cohort studies, and case–control studies. No randomized control trials were found. We excluded review articles and case reports. Each author assessed each article independently. To determine the final eligibility, the authors separately reviewed titles, abstracts, and full-text articles. The general characteristics of the studies, including journal name, article title, the first author’s name, study design, sample size, population characteristics, endocrine disruptors’ influence on male fertility, publication year, and country of study, were extracted from the studies and evaluated. Disagreements were settled through scientific discussions. All authors performed control checks between the final data utilized in the systematic review and the source articles to prevent extraction and data input errors.
The review was performed in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement [50].
3. Results and Discussion
3.1. Literature Search
The search method turned up 27 possibly pertinent articles. By reviewing the lists of citations in the articles thus obtained, we then looked for additional articles that could meet our inclusion criteria. A total of 39 publications was identified for additional full-text evaluation based on the inclusion criteria. For this review, we incorporated publications looking at correlations with bisphenols, phthalates, and parabens. Finally, we included 25 articles. Figure 1 presents a PRISMA flow diagram of the association of endocrine-disrupting chemicals—bisphenols, phthalates, and parabens—with human semen quality and oxidative stress.
3.2. The Association of Endocrine-Disrupting Chemicals with Human Semen Quality and Oxidative Stress
Table 1 summarizes the reported studies, with study characteristics and main findings on the effects of endocrine-disrupting chemicals—bisphenols, phthalates, and parabens—on human semen quality and oxidative stress.
3.2.1. BPA, Semen Quality, and DNA Integrity
There were 10 studies identified studying the relationships between BPA, semen quality, and oxidative stress [51,52,53,54,55,56,57,58,59,60]. Some studies showed that higher levels of urinary BPA were associated with higher levels of serum male reproductive hormones (e.g., LH, testosterone) and, consequently, with impaired semen quality, e.g., sperm motility, concentration, counts, and morphology. Nevertheless, we can see that various studies are contradictory, and some of them show no a negative effects of EDCs on reproductive hormones and sperm quality. The main reason for this is probably that different groups of men were included in the studies—from young men with normal sperm quality to men with the most severe forms of infertility (for example, azoospermia)—and that the studies were cross-sectional. However, the negative effects of BPA were more evident in the groups of infertile men.
Seminal BPA, but not plasma BPA, was discovered by Vitku et al., to be inversely associated with sperm concentration, count, and morphology [53]. This finding is consistent with the recent research demonstrating that exposure to BPs is linked to a variety of adverse effects, including damage to the blood–testis barrier in the testes, a well as direct effects on spermatozoa. In addition to urine, BPs have also been found in human seminal plasma, although it is unclear how these substances might be transferred through the seminal fluid. Transport across the blood–testis barrier may be important, according to some authors.
A recent study compared the ejaculates of normozoospermic men and men post-vasectomy with interrupted vas deferens without testicular products. These men’s seminal plasma and urine were tested for BPA, BPS, and BPF concentrations. It was determined that the ratio of urinary and seminal plasma contents of BPs did not differ among men in the two groups. It was concluded that BPs are predominantly transported into seminal plasma not through testicular tissue, but through comparable ejaculate volume ratios that are applied similarly to other routes of transmission. Toxic bisphenols mostly reach the seminal plasma through the secretions of accessory glands and do so to a far greater extent than through testicular tissue [75].
Urinary BPA concentrations were discovered by Meeker et al. [51] and Omran et al. [55] to be inversely related to semen quality and positively related to DNA damage [51,55], as well as being inversely correlated with antioxidant levels [55]. As many in vitro and in vivo studies suggest that the depleted cholesterol in Leydig cells is responsible for lower testosterone production, oxidative stress may be linked to DNA damage by affecting steroid production. Additionally, the knockdown of peroxisome proliferator-activated receptor alpha (PPAR-α) remarkably ameliorated the downregulation of cholesterogenesis-related genes such as Hmgcs1, Hmgcr, and Srebf2, indicating that PPAR-α plays a critical role in BP-induced testicular dysfunction. Overall, these studies showed that BPS, BPF, and BPAF could have harmful effects on testicles comparable to those of BPA, and linked to the PPAR-α pathway [36].
Another crucial truth is that obesity—a common contemporary companion of the industrialized world—exacerbates the damaging effects of BPA on human spermatogenesis. Urinary BPA concentrations were shown to be inversely correlated with sperm count per ejaculate in obese males according to Hu et al., who assessed the association with semen volume, sperm count per ejaculate, sperm concentration, and sperm motility in 357 men. Furthermore, metabolomics studies were carried out to find metabolites connected to this interaction. Capric acid, dodecanoic acid, L-palmitoylcarnitine, and niacinamide were among the detected metabolites; these are known to be important in fatty acid oxidation and the tricarboxylic acid cycle, indicating higher oxidative stress linked to male reproductive dysfunction [54]. The significance of dietary exposure to BPA was supported by Caporossi et al., who found a strong positive correlation between the consumption of canned food and the levels of BPA, as well as negative correlation between the usage of plastic food storage containers and semen volume [57].
3.2.2. Phthalates, Semen Quality, and DNA Integrity
We found 10 studies studying the association of phthalates and their metabolites with semen quality and oxidative stress [61,62,63,64,65,66,67,68,69,70]. All of them showed a positive correlation between levels of phthalates in urine and at least one semen parameter indicative of low semen quality. The associations were more common in groups of men with infertility than groups of fertile men. Hauser et al., revealed that low sperm concentration and motility were related to higher MBP levels [62]. Jurewitz et al., confirmed association of higher levels of urinary phthalate metabolites and lower sperm motility and testosterone levels, as well as increased sperm DNA damage and sperm aneuploidy [64]. MEHP concentrations were inversely associated with Y:X sperm chromosome ratios [68]. Bloom et al., also revealed a positive association between phthalate levels and percentages of abnormal sperm morphology—especially with regard to sperm heads [66]. Another three studies demonstrated a positive relationship of levels of urinary phthalates with sperm DNA damage [61,64,65].
According to earlier research, exposure to phthalates can impair normal spermatogenesis and steroidogenesis due to oxidative stress in the male reproductive organs—particularly in the testes and epididymis. By causing oxidative stress in germ cells or apoptosis in target Sertoli cells, they impede the spermatogenic process. Phthalates also reduce the Leydig cells’ ability to produce steroidogenic enzymes by increasing ROS. As expected, studies show that exposure to phthalate chemicals during pregnancy and postnatally may result in decreased sperm counts and other reproductive defects in the young [40]. Paternal urinary concentrations of DEHP metabolites were also correlated with higher failure rates of in vitro fertilization (IVF) treatment [41].
3.2.3. Parabens, Semen Quality, and DNA Integrity
There were five studies identified studying the association of parabens with semen quality and oxidative stress [42,71,72,73,74]. Only two studies revealed the correlation of urinary paraben concentrations with a low sperm count and decreased motility [42,74]. In addition, Jurewicz et al., found a strong correlation between urinary paraben concentrations and an increase in the abnormal morphology percentage and DNA fragmentation of spermatozoa, as well as a decrease in serum testosterone levels [42]. In studies where no correlation was revealed, there was temporal intraindividual variability [71], or the sample size was small [72], or the average age of men was low, suggesting that in young men, urinary parabens may not negatively affect their reproductive function [73].
3.3. EDCs, Oxidative Stress, and Human Spermatozoa
Our review of the correlation of EDCs wih semen quality and oxidative stress suggests that negative associations were more frequently related to BPA and phthalates, and less frequently to parabens. The question remains—what are the possible mechanisms of action of EDCs on human spermatozoa? Figure 2 presents the mechanisms of action of EDCs on male fertility.
EDCs may be able to bind to receptors on human spermatozoa and change sperm functions, according to mounting evidence [76]. The interaction between estrogenic compounds and nongenomic receptors for estrogen on human sperm membranes has been demonstrated. The nongenomic receptor for estradiol (E2), which is located on the sperm plasma membrane, mediates the effects of this hormone on sperm’s intracellular calcium concentrations and biological response to progesterone (P). It was shown that 17βE2 expresses an inhibitory effect on P-mediated calcium influx and acrosome reaction (AR) in human spermatozoa. The anti-estrogens tamoxifen (Tx) and ICI 164,384 (ICI) induced only a slight increase in calcium influx; however, as in the case of 17βE2, this resulted in a reduction in P-stimulated calcium influx. Both agents reduced the calcium response to 17βE2 without affecting 17βE2-induced inhibition of the calcium response to P. Tx alone did not affect spontaneous or P-stimulated AR, but partially reverted the inhibitory effect of 17βE2. These results indicate that both estrogens act as agonists of the membrane estrogen receptors of human spermatozoa. On the other hand, the xenoestrogen BPA and octylphenol polyethoxylate (OP) did not express any direct effect on calcium fluxes or AR in human spermatozoa, whether in basal conditions or in response to P challenge. Although it has been suggested that environmental estrogens can imitate the actions of estrogen in other cells—perhaps by acting through genomic receptors—in human spermatozoa they have not been shown to tamper with 17βE2′s binding to its membrane receptor or the short-term effects of this hormone. These data indicate that in human spermatozoa the membrane receptor for E2 differs from the genomic receptor in terms of both biochemistry and pharmacology [77].
EDCs affect human spermatozoa in different ways:
(a) Sperm mitochondria: The study of Skibińska et al. showed that human sperm mitochondria are targets for both 17βE2 and EDCs. Two-hour incubation of spermatozoa with E2, genistein, and BPA did not alter the cell vitality or stimulate phosphatidylserine membrane translocation in spermatozoa. However, incubation of spermatozoa with E2 or BPA separately, as well as incubation with the three ligands together, altered the mitochondrial membrane potential. Incubation of spermatozoa with all three ligands significantly increased the mitochondrial superoxide anion levels in the spermatozoa. The reaction to the mixture of 17βE2 and xenoestrogens including BPA suggests a synergistic mechanism of action. Moreover, xenoestrogens may increase the sensitivity of spermatozoa to 17βE2 [78]. In another study, exposure of suspensions of motile human spermatozoa to different BPA concentrations for 4 h led to a reduction in mitochondrial membrane potential. It was also associated with an increased mitochondrial generation of superoxide anions, caspase-9 and caspase-3 activity, and decreased motility. Decreased sperm motility was observed at BPA ≥ 400 μM. Twenty hours of exposure of spermatozoa to 300 μM BPA resulted in a significant decrease in sperm vitality associated with complete sperm immobilization. Finally, 300 μM BPA also produced significant oxidative DNA damage, as revealed by the formation of the oxidized base adduct 8-hydroxy-2′-deoxyguanosine. It was concluded that BPA has an impact on the integrity of human sperm by causing pro-oxidative/apoptotic mitochondrial malfunction [79]. Interestingly, it was found that human spermatozoa are shielded against mitochondrial failure caused by exposure to BPA by an aqueous extract of the Eruca sativa plant [80]. Due to their lack of impact on the viability, motility, and mitochondrial activities of human sperm, BPS and BPF appear to be safer substitutes for BPA [81]. These findings might aid regulatory agencies in identifying safer compounds to replace BPA in the manufacture of plastics on a large scale.
Human spermatozoa exposed to the phthalates DEHP and MEHP did not exhibit any changes in their motility, viability, membrane integrity, mitochondrial activity, or homeostasis of reactive oxygen species [82]. On the other hand, a negative correlation was established between semen phthalate (DEHP) levels and sperm quality, along with positive associations with depolarized mitochondria, elevated ROS production, and lipid peroxidation [39]. Moreover, mitochondrial DNA copy numbers were positively associated with urinary concentrations of the phthalate metabolite monocarboxyisononyl phthalate (MCNP) after adjusting for age, body mass index, current smoking, race, and measurement batch in a cohort of men included in an IVF program [83]. It was proposed that the key to determining how parabens contribute to a decline in male reproductive capacity is through their interaction with mitochondrial function in the testes [84].
Furthermore, it was found that parabens also generated ROS in human spermatozoa. It was shown that combinations of parabens may induce the production of cytosolic and mitochondrial ROS in vitro, reducing sperm motility and viability in a dose-dependent manner [43].
(b) Sperm DNA fragmentation: Various studies have shown that estrogenic compounds cause oxidative stress and damage to DNA integrity—such as DNA fragmentation—in human spermatozoa. Different estrogens and estrogen analogues, including 17βE2 and BPA, increased sperm redox activity, which was linked to a severe reduction in spermatozoa motility and an increase in DNA fragmentation [85]. According to Meeker et al., there were decreases in sperm concentration, motility, and morphology, as well as an increase in sperm DNA damage, related to higher BPA urinary levels [51]. In another study, total BPA levels in the urine of 50 infertile men were found to be inversely correlated with semen quality and antioxidant levels, and positively correlated with sperm DNA damage and seminal plasma lipid peroxidation [55].
The study of Pant et al., revealed a negative correlation between semen phthalate levels (DEHP) and sperm quality, and a positive association with sperm DNA fragmentation was also established [39]. The concentration of DEHP in the seminal plasma was correlated positively with the ROS level and sperm DNA fragmentation index (DFI), but negatively with the percentage of progressively motile sperm [86]. Exposure of human spermatozoa to the phthalate DEHP in vitro significantly increased the sperm DNA fragmentation [87].
Moreover, a relationship between parabens’ potential to activate ROS production and cause oxidative DNA damage in spermatozoa and the length of their alkyl chains was discovered. At concentrations used clinically, methylparaben reduced the motility and cell viability of human sperm while increasing the generation of ROS and oxidative DNA damage [43].
(c) Apoptosis or programmed cell death: Regulating apoptosis in germ cells is essential for preserving regular sperm production. Numerous studies have demonstrated that EDCs—especially BPA—cause sperm production to decline and induce germ cell apoptosis. Activation of ADAM17 and p38 MAPK is involved in the BPA-induced apoptosis of male germ cells [88]. The exposure of human motile sperm suspensions to scalar BPA concentrations for four hours produced an increase in caspase-9 and caspase-3 activation, along with impairment of motility [89].
Some studies have suggested that, similarly to BPs, exposure to phthalates may induce sperm apoptosis. The evidence was provided that phthalate exposure in humans was linked to higher protamine levels in the spermatozoa, which may play a role in sperm apoptosis [90]. The study of Marchiani et al., showed that after in vitro incubation of human spermatozoa with phthalate, sperm’s progressive motility was dramatically reduced. Moreover, exposure to this toxic agent also induced spontaneous sperm acrosome reaction, reduced the physiological response to progesterone, and increased caspase activity, all of which suggest triggering of an apoptotic pathway [91]. It was also found that apoptosis-related gene polymorphisms might contribute to the effects of phthalate exposure on male reproductive health [92].
Furthermore, parabens can generate mitochondrial ROS in human spermatozoa, related to increased apoptosis and reduced vitality of the spermatozoa, along with decreased sperm motility [43,93].
(d) Sperm epigenetics: Methylation of long interspersed nucleotide elements (LINE-1) is a marker of genome-wide methylation status in cells. It was discovered that BPA exposure is linked to LINE-1 hypomethylation in human spermatozoa. Sperm LINE-1 methylation levels were considerably lower in BPA-exposed workers compared to unexposed individuals, according to a study by Miao et al. Additionally, log-transformed urine BPA levels were found to be negatively correlated with sperm LINE-1 methylation by linear regression analysis. Interestingly, this was not found for peripheral blood cells. Due to exposure to BPA, it was determined that these findings might have an impact on male reproductive health [94]. Similarly, Zheng et al., found genome-wide changes in DNA hydroxymethylation in the sperm of Chinese males who had been exposed to BPA. Some of the BPA-affected genes may be involved in the response to DNA damage in spermatozoa brought on by BPA. These findings also indicate that exposure to BPA affects DNA hydroxymethylation in a manner that is dependent on trimethylation of H3 in human spermatogenesis which, in turn, interferes with gene expression in human spermatozoa [95]. BPA exposure also induced hydroxymethylation of the acetylcholinesterase (ACHE) gene in exposed men [96]. This finding is quite important, because the ACHE gene is a sperm-expressed gene encoding the acetylcholine-hydrolyzing enzyme acetylcholinesterase, and participates in the apoptosis of different cells, including spermatozoa. In another study, men from infertile couples who underwent IVF had 131 differentially methylated regions (DMRs) in their spermatozoa, all of which were related to at least one urinary phthalate metabolite. These findings imply that paternal adult environmental factors may influence epigenetic reprogramming during spermatogenesis and influence the early-life development [97].
The results of another study conducted by the same group clearly demonstrated an unfavorable relationship between male preconception urinary phthalate metabolite concentrations and blastocyst quality during IVF, which most likely developed after genomic activation [98]. Similar negative correlations were observed between male urine phthalate metabolite concentrations and the chance of high-quality blastocysts. Such findings may have clinical and public health significance both for the couples undergoing IVF and for the general population if they are confirmed by additional research. Additionally, it has also been shown that DNA methylation plays a role in mediating the positive correlation between low-level environmental phthalate exposure and sperm motility. For instance, epigenetic modification via LINE-1 DNA methylation has been shown to have mediating effects in the relationship between DEHP exposure and sperm motility in men [99].
To the best of our knowledge, there are no such data for parabens to date.
The observations about the epigenetic effects of EDCs are very worrying, as epigenetic abnormalities—especially of the sperm—may be linked to individual development, and may be transmitted to subsequent generations.
(e) Ratio of Y- and X-chromosome-bearing live spermatozoa: In certain developed nations, but not all, a trend toward a lower ratio of male to female births has been observed recently [68]. Interestingly, it was proven that some EDCs may affect the Y:X sperm chromosome ratio [79]. The viability, motility, and capacitation of sperm were affected by all EDCs examined, including genistein (Gen), BPA, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), dibromochloropropane (DBCP), and diazinon (Diaz). When sperm were treated with TCDD, DBCP, and Diaz, the Y:X ratio of live spermatozoa was significantly lower than it was in control spermatozoa. These findings revealed that some EDCs had a greater impact on the viability of Y spermatozoa than X spermatozoa, suggesting that a decrease in Y-carrying sperm viability may lead to offspring with a sex ratio that is disproportionately female at birth [89]. Similarly, the Y:X sperm chromosomal ratio in human spermatozoa was found to be negatively associated with EDCs such as 5OH MEHP, CDCCA to TDCCA, and 1-OHP for BPA. This suggests a relationship between the concentrations of metabolites from common environmental endocrine disruptors (e.g., phthalates, synthetic pyrethroids, polycyclic aromatic hydrocarbons) and the ratio of the sex chromosomes in human spermatozoa [68].
(f) Sperm protein composition: Using a contemporary approach of proteomics, it was discovered that BPA exposure is associated with the deregulation of proteins such as actin (ACTB), caspase-3 (CASP3), glyceraldehyde-3-phosphate dehydrogenase (GAPDHS), glutathione peroxidase 4 (GPX4), outer dense fiber protein 2 (ODF2), Ras-related protein Rab-2A (RAB2A), sperm surface protein Sp17 (SPA17), and triosephosphate isomerase (TPI1) in spermatozoa. All of these proteins play significant roles in processes related to male fertility, including sperm motility (ACTB, ODF2, GADPHS), acrosome reaction (ACTB), apoptosis (CASP3), spermatogenesis and sperm maturation (GPX4), acrosome biogenesis (RAB2A), and sperm binding to oocytes’ zona pellucida (SPA17, TPI1) [100].
3.4. Antioxidant Therapy for Subfertile Men
There is more and more research proving the negative impact of EDCs on semen quality and spermatozoa in humans, and these findings cannot be ignored. They require the attention and action of the entire society at all levels. There is a pressing question of how to avoid all of these negative influences. Prevention is certainly one of the options, both at the level of society and at the individual level. Experts in reproductive medicine also face this challenge—especially in targeting oxidative stress with antioxidant supplementation. Numerous studies on the effects of antioxidant supplements on semen quality have been conducted, some revealing positive effects of different antioxidants on different semen parameters [101], while others determining no effects [101,102].
The recent Cochrane review “Antioxidants for male subfertility” tried to answer the question of whether supplementary oral antioxidants improve fertility results in subfertile males as compared to men receiving a placebo, no treatment, or another antioxidant therapy. In a review by Cochrane authors, 18 different antioxidants were compared in 90 randomized controlled trials with a placebo, no treatment, or another antioxidant in a cohort of 10,303 subfertile men. The results of 12 small-to-medium-sized randomized controlled trials suggested that antioxidant supplements taken by subfertile males from infertile couples visiting an infertility clinic may increase the likelihood of a live birth, but the overall certainty of the evidence was very low. Evidence with a low degree of certainty indicates that clinical pregnancy rates could rise following antioxidant therapy. Overall, there is no evidence that antioxidant therapy increases the chance of miscarriage. Therefore, subfertile couples should be advised that the existing research on the efficacy of antioxidant therapy in improving male fertility is inconclusive [103]. The question of antioxidant therapy that could mitigate the toxicity of EDCs in men facing fertility problems is therefore still open, and needs to be further researched.
4. Conclusions
Our review revealed that some studies link increased urine BPA concentrations to lower semen quality and DNA damage; these detrimental effects of BPA were more evident in infertile men. Considering phthalates, all studies found positive associations between urinary levels of phthalates and at least one semen parameter indicative of low semen quality. In addition, increased sperm DNA damage and sperm aneuploidy were linked to higher urinary levels of phthalate metabolites. Some studies have shown a correlation between urinary paraben concentrations and a decline in sperm count and motility, as well as an increase in sperm DNA damage. Our findings show that EDCs can elevate ROS production and lipid peroxidation, increase apoptosis, induce epigenetic modifications, and change Y:X sperm chromosome ratios and sperm protein composition.
Conceptualization, I.V.-K., S.I.-K. and B.P.; investigation, I.V.-K., S.I.-K. and B.P.; resources, S.I.-K.; writing—original draft preparation, I.V.-K., S.I.-K. and B.P.; writing—review and editing, I.V.-K., S.I.-K. and B.P.; visualization, S.I.-K.; supervision, I.V.-K. and B.P.; project administration, S.I.-K. and B.P.; funding acquisition, B.P. All authors have read and agreed to the published version of the manuscript.
Not applicable.
Not applicable.
The data are contained within the article.
The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Enlarge this image.Figure 1. PRISMA flow diagram. Association of endocrine-disrupting chemicals—bisphenols, phthalates, and parabens—with human semen quality and oxidative stress.
Enlarge this image.Figure 2. Mechanisms of action of endocrine-disrupting chemicals (EDCs) on male fertility.
Association of endocrine-disrupting chemicals—bisphenols, phthalates, and parabens—with human semen quality and oxidative stress: review of the studies.
| Study/Author | Year | Number of Patients | EDC | Outcome |
|---|---|---|---|---|
| BPA | ||||
| Meeker et al. [ |
2010 | 190 men at an infertility clinic |
|
|
| Lassen et al. [ |
2014 | 308 young Danish men from the general population |
|
|
| Vitku et al. [ |
2016 | 191 men with different degrees of (in)fertility from an infertility clinic |
|
|
| Hu et al. [ |
2017 | 357 obese men |
|
|
| Omran et al. [ |
2018 | 100 men: 50 infertile men and 50 control men with normal semen quality |
|
|
| Adoamnei et al. [ |
2018 | 215 healthy men, aged 18–23 years, recruited in southern Spain |
|
|
| Caporossi et al. [ |
2020 | 105 men at an infertility clinic |
|
|
| Palak et al. [ |
2021 | 116 men: 20 infertile men with non-obstructive azoospermia, 46 infertile men with oligoasthenoteratozoospermia, and 50 control normospermic men |
|
|
| Benson et al. [ |
2021 | 556 young adult Danish men, aged 18–20 years |
|
|
| Chen et al. [ |
2022 | 984 Chinese men from an infertility clinic |
|
|
| Phthalates | ||||
| Duty et al. [ |
2003 | 168 men |
|
|
| Hauser et al. [ |
2006 | 463 male partners from subfertile couples |
|
|
| Liu et al. [ |
2012 | 150 Chinese men of reproductive age |
|
|
| Jurewitz et al. [ |
2013 | 269 men with normal semen concentration or slight oligozoospermia |
|
|
| Axelsson et al. [ |
2015 | 314 young Swedish men from the general population |
|
|
| Bloom et al. [ |
2015 | 501 men from the United States—male partners in couples discontinuing contraception to become pregnant—general population |
|
|
| Wang et al. [ |
2015 | 1040 Chinese infertile men from an infertility clinic |
|
|
| Jurewicz et al. [ |
2016 | 194 men aged less than 45 years, with normal sperm concentration or with slight oligozoospermia |
|
|
| Thurston et al. [ |
2016 | 420 men from the US—fertile partners of pregnant women |
|
|
| Chen et al. [ |
2017 | 796 male students who experienced a relocation of campuses and shifting environmental exposure |
|
|
| Parabens | ||||
| Meeker et al. [ |
2011 | 190 male partners attending an infertility clinic, aged between 18 and 55 years, without post-vasectomy status |
|
|
| Jurewiczet al. [ |
2017 | 315 men who attended an infertility clinic for diagnostic purposes, with normal semen concentrations |
|
|
| Nishihama et al. [ |
2017 | 42 male partners of couples who visited a gynecology clinic for infertility consultation |
|
|
| Adoamnei et al. [ |
2018 | Cross-sectional study with 215 young university students (18–23 years old) recruited in southern Spain |
|
|
| Smarr et al. [ |
2018 | 501 male partners of couples planning to become pregnant |
|
|
Abbreviations: A, androstenedione; BP, butyl paraben; BPA, bisphenol A; BPF, bisphenol F; BPS, bisphenol S; DEHP, di-2-ethylhexyl-phthalate metabolites; DNA, deoxyribonucleic acid; EDC, endocrine-disrupting chemical; E2, estradiol; T, testosterone; LH, luteinizing hormone; EP, ethyl paraben; E2, estradiol; MBP, mono-n-butyl phthalate; MBzP, monobenzyl phthalate; MCMHP, mono-[2-(carboxymethyl) hexyl] phthalate; MCPP, mono-3-carboxypropyl phthalate; MECPP, mono-2-ethyl-5-carboxypentyl phthalate; MEOHP, mono-2-ethyl-5-oxohexyl phthalate; MEHP, mono-2-ethylhexyl phthalate; MEHHP, mono-2-ethyl-5-hydroxyhexyl phthalate; MEP, monoethyl phthalate; MiNP, monoisononyl phthalate; MMP, monomethyl phthalate; MnBP, mono-n-butyl phthalate; MnOP, mono-n-octyl phthalate; MNP, monoisononyl phthalate; MiBP, monoisobutyl phthalate; MP, methyl paraben; PP, propyl paraben.
References
1. (EDSTAC) USEPA EDSaTAC. Endocrine Disrupter Screening and Testing Advisory Committee Final Report. Available online: http://www.epa.gov/endocrine-disruption/endocrine-disruptor-screening-and-testing-advisory-committee-edstac-final (accessed on 13 July 2022).
2. Safe, S.H. Endocrine Disruptors and Human Health—Is There a Problem? An Update. Environ. Health Perspect.; 2000; 108, pp. 487-493. [DOI: https://dx.doi.org/10.1289/ehp.00108487]
3. Baskin, L.S.; Himes, K.; Colborn, T. Hypospadias and Endocrine Disruption: Is There a Connection?. Environ. Health Perspect.; 2001; 109, pp. 1175-1183. [DOI: https://dx.doi.org/10.1289/ehp.011091175] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11713004]
4. Balabanič, D.; Rupnik, M.; Krivograd Klemenčič, A. Negative impacts of endocrine-disrupting compounds on human reproductive health. Reprod. Fertil. Dev.; 2011; 23, pp. 403-416. [DOI: https://dx.doi.org/10.1071/RD09300] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21426858]
5. Coster, S.; Larebeke, N. Endocrine-Disrupting Chemicals: Associated Disorders and Mechanisms of Action. J. Environ. Public Health; 2012; 2012, 713696. [DOI: https://dx.doi.org/10.1155/2012/713696] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22991565]
6. Campion, S.; Catlin, N.; Heger, N.; McDonnell, E.V.; Pacheco, S.E.; Saffarini, C.; Sandrof, M.A.; Boekelheide, K. Male Reprotoxicity and Endocrine Disruption. Exp. Suppl.; 2012; 101, pp. 315-360. [DOI: https://dx.doi.org/10.1007/978-3-7643-8340-4_11]
7. Sharlip, I.D.; Jarow, J.P.; Belker, A.M.; Lipshultz, L.I.; Sigman, M.; Thomas, A.J.; Schlegel, P.N.; Howards, S.S.; Nehra, A.; Damewood, M.D. et al. Best practice policies for male infertility. Fertil. Steril.; 2002; 77, pp. 873-882. [DOI: https://dx.doi.org/10.1016/S0015-0282(02)03105-9]
8. Diamanti-Kandarakis, E.; Bourguignon, J.P.; Giudice, L.C.; Hauser, R.; Prins, G.S.; Soto, A.M.; Zoeller, R.T.; Gore, A.C. Endocrine-disrupting chemicals: An Endocrine Society scientific statement. Endocr. Rev.; 2009; 30, pp. 293-342. [DOI: https://dx.doi.org/10.1210/er.2009-0002]
9. Sharma, A.; Mollier, J.; Brocklesby, R.; Caves, C.; Jayasena, C.N.; Minhas, S. Endocrine-disrupting chemicals and male reproductive health. Reprod. Med. Biol.; 2020; 19, pp. 243-253. [DOI: https://dx.doi.org/10.1002/rmb2.12326]
10. Quilaqueo, N.; Villegas, J.V. Endocrine disruptor chemicals. A review of their effects on male reproduction and antioxidants as a strategy to counter it. Andrologia; 2022; 54, e14302. [DOI: https://dx.doi.org/10.1111/and.14302]
11. Sharma, R.K.; Agarwal, A. Role of reactive oxygen species in male infertility. Urology; 1996; 48, pp. 835-850. [DOI: https://dx.doi.org/10.1016/S0090-4295(96)00313-5]
12. Buhler, D.R.; Miranda, C. Antioxidant Activities of Flavonoids; Oregon State University: Corvallis, OR, USA, 2000.
13. Rivlin, J.; Mendel, J.; Rubinstein, S.; Etkovitz, N.; Breitbart, H. Role of hydrogen peroxide in sperm capacitation and acrosome reaction. Biol. Reprod.; 2004; 70, pp. 518-522. [DOI: https://dx.doi.org/10.1095/biolreprod.103.020487]
14. Agarwal, A.; Virk, G.; Ong, C.; du Plessis, S.S. Effect of oxidative stress on male reproduction. World J. Men’s Health; 2014; 32, pp. 1-17. [DOI: https://dx.doi.org/10.5534/wjmh.2014.32.1.1]
15. Gosalvez, J.; Tvrda, E.; Agarwal, A. Free radical and superoxide reactivity detection in semen quality assessment: Past, present, and future. J. Assist. Reprod. Genet.; 2017; 34, pp. 697-707. [DOI: https://dx.doi.org/10.1007/s10815-017-0912-8]
16. Darbandi, M.; Darbandi, S.; Agarwal, A.; Sengupta, P.; Durairajanayagam, D.; Henkel, R.; Sadeghhi, M.R. Reactive oxygen species and male reproductive hormones. Reprod. Biol. Endocrinol.; 2018; 16, 87. [DOI: https://dx.doi.org/10.1186/s12958-018-0406-2]
17. Kao, S.H.; Chao, H.T.; Chen, H.W.; Hwang, T.I.; Liao, T.L.; Wei, Y.H. Increase in oxidative stress in human sperm with lower motility. Fertil. Steril.; 2008; 89, pp. 1183-1190. [DOI: https://dx.doi.org/10.1016/j.fertnstert.2007.05.029]
18. Verit, F.F.; Verit, A.; Kocyigit, A.; Ciftci, H.; Celik, H.; Koksal, M. No increase in sperm DNA damage and seminal oxidative stress in patients with idiopathic infertility. Arch. Gynecol. Obstet.; 2006; 274, pp. 339-344. [DOI: https://dx.doi.org/10.1007/s00404-006-0172-9]
19. Aitken, R.J.; De Iuliis, G.N.; Finnie, J.M.; Hedges, A.; McLachlan, R.I. Analysis of the relationships between oxidative stress, DNA damage and sperm vitality in a patient population: Development of diagnostic criteria. Hum. Reprod.; 2010; 25, pp. 2415-2426. [DOI: https://dx.doi.org/10.1093/humrep/deq214]
20. Agarwal, A.; Ahmad, G.; Sharma, R. Reference values of reactive oxygen species in seminal ejaculates using chemiluminescence assay. J. Assist. Reprod. Genet.; 2015; 32, pp. 1721-1729. [DOI: https://dx.doi.org/10.1007/s10815-015-0584-1]
21. Agarwal, A.; Saleh, R.A.; Bedaiwy, M.A. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil. Steril.; 2003; 79, pp. 829-843. [DOI: https://dx.doi.org/10.1016/S0015-0282(02)04948-8]
22. Aitken, R.J.; Clarkson, J.S.; Fishel, S. Generation of reactive oxygen species, lipid peroxidation, and human sperm function. Biol. Reprod.; 1989; 41, pp. 183-197. [DOI: https://dx.doi.org/10.1095/biolreprod41.1.183]
23. Tomza-Marciniak, A.; Stepkowska, P.; Kuba, J.; Pilarczyk, B. Effect of bisphenol a on reproductive processes: A review of in vitro, in vivo and epidemiological studies. J. Appl. Toxicol.; 2018; 38, pp. 51-80. [DOI: https://dx.doi.org/10.1002/jat.3480]
24. Vandenberg, L.N.; Hauser, R.; Marcus, M.; Olea, N.; Welshons, W.V. Human exposure to bisphenol a (BPA). Reprod. Toxicol.; 2007; 24, pp. 139-177. [DOI: https://dx.doi.org/10.1016/j.reprotox.2007.07.010]
25. Vandenberg, L.N.; Maffini, M.V.; Sonnenschein, C.; Rubin, B.S.; Soto, A.M. Bisphenol-A and the great divide: A review of controversies in the field of endocrine disruption. Endocr. Rev.; 2009; 30, pp. 75-95. [DOI: https://dx.doi.org/10.1210/er.2008-0021]
26. Peretz, J.; Vrooman, L.; Ricke, W.A.; Hunt, P.A.; Ehrlich, S.; Hauser, R.; Padmanabhan, V.; Taylor, H.S.; Swan, S.H.; VandeVoort, C.A. et al. Bisphenol a and reproductive health: Update of experimental and human evidence, 2007–2013. Environ. Health Perspect.; 2014; 122, pp. 775-786. [DOI: https://dx.doi.org/10.1289/ehp.1307728]
27. Chahoud, I. Weak sperm--thick prostate. Danger from the baby bottle? (interview by Petra Eiden). MMW Fortschr. Med.; 2000; 142, 18.
28. Kang, J.H.; Kondo, F.; Katayama, Y. Human exposure to bisphenol A. Toxicology; 2006; 226, pp. 79-89. [DOI: https://dx.doi.org/10.1016/j.tox.2006.06.009]
29. Chapin, R.E.; Adams, J.; Boekelheide, K.; Gray, L.E., Jr.; Hayward, S.W.; Lees, P.S.; McIntyre, B.S.; Portier, K.M.; Schnorr, T.M.; Selevan, S.G. et al. NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. Birth Defects Res. B Dev. Reprod. Toxicol.; 2008; 83, pp. 157-395. [DOI: https://dx.doi.org/10.1002/bdrb.20147]
30. Shelby, M.D. NTP-CERHR monograph on the potential human reprodutive and developmental effects of bisphenol A. Ntp. Cerhr. Mon.; 2008; 22, pp. 1-64.
31. FAO/WHO. Final Report, Including Report of Stakeholder Meeting on Bisphenol A. Proceedings of the Joint Food and Agriculture Organization of the United Nations and World Health Organization (FAO/WHO) Expert Meeting to Review Toxicological and Health Aspects of Bisphenol A; Ottawa, ON, Canada, 1–5 November 2010.
32. Geens, T.; Goeyens, L.; Kannan, K.; Neels, H.; Covaci, A. Levels of bisphenol A in thermal paper receipts from Belgium and estimation of human exposure. Sci. Total Environ.; 2012; 435–436, pp. 30-33. [DOI: https://dx.doi.org/10.1016/j.scitotenv.2012.07.001] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22846760]
33. Vandenberg, L.N.; Hunt, P.A.; Myers, J.P.; Vom Saal, F.S. Human exposures to bisphenol A: Mismatches between data and assumptions. Rev. Environ. Health; 2013; 28, pp. 37-58. [DOI: https://dx.doi.org/10.1515/reveh-2012-0034] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23612528]
34. European Food Safety Authority (EFSA). Scientific Opinion on the Risks to Public Health Related to the Presence of Bisphenol A (BPA) in Foodstuffs: Executive Summary; 1st ed. European Food Safety Authority: Parma, Italy, 2015.
35. Castellini, C.; Totaro, M.; Parisi, A.; D’Andrea, S.; Lucente, L.; Cordeschi, G.; Francavilla, S.; Francavilla, F.; Barbonetti, A. Bisphenol A and Male Fertility: Myths and Realities. Front. Endocrinol.; 2020; 11, 353. [DOI: https://dx.doi.org/10.3389/fendo.2020.00353] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32595601]
36. Gao, Z.; Liu, S.; Tan, L.; Gao, X.; Fan, W.; Ding, C.; Li, M.; Tang, Z.; Shi, X.; Luo, Y. et al. Testicular toxicity of bisphenol compounds: Homeostasis disruption of cholesterol/testosterone via PPARα activation. Sci. Total Environ.; 2022; 836, 155628. [DOI: https://dx.doi.org/10.1016/j.scitotenv.2022.155628] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/35504394]
37. Ge, R.S.; Chen, G.R.; Tanrikut, C.; Hardy, M.P. Phthalate ester toxicity in Leydig cells: Developmental timing and dosage considerations. Reprod. Toxicol.; 2007; 23, pp. 366-373. [DOI: https://dx.doi.org/10.1016/j.reprotox.2006.12.006] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17258888]
38. Basso, C.G.; de Araújo-Ramos, A.T.; Martino-Andrade, A.J. Exposure to phthalates and female reproductive health: A literature review. Reprod. Toxicol.; 2022; 109, pp. 61-79. [DOI: https://dx.doi.org/10.1016/j.reprotox.2022.02.006]
39. Pant, N.; Shukla, M.; Kumar Patel, D.; Shukla, Y.; Mathur, N.; Kumar Gupta, Y.; Saxena, D.K. Correlation of phthalate exposures with semen quality. Toxicol. Appl. Pharmacol.; 2008; 231, pp. 112-116. [DOI: https://dx.doi.org/10.1016/j.taap.2008.04.001]
40. Sedha, S.; Kumar, S.; Shukla, S. Role of Oxidative Stress in Male Reproductive Dysfunctions with Reference to Phthalate Compounds. Urol. J.; 2015; 12, pp. 2304-2316.
41. Mínguez-Alarcón, L.; Bellavia, A.; Gaskins, A.J.; Chavarro, J.E.; Ford, J.B.; Souter, I.; Calafat, A.M.; Hauser, R.; Williams, P.L. EARTH Study Team. Paternal mixtures of urinary concentrations of phthalate metabolites, bisphenol A and parabens in relation to pregnancy outcomes among couples attending a fertility center. Environ. Int.; 2021; 146, 106171. [DOI: https://dx.doi.org/10.1016/j.envint.2020.106171]
42. Jurewicz, J.; Radwan, M.; Wielgomas, B.; Dziewirska, E.; Karwacka, A.; Klimowska, A.; Kałużny, P.; Radwan, P.; Bochenek, M.; Hanke, W. Human Semen Quality, Sperm DNA Damage, and the Level of Reproductive Hormones in Relation to Urinary Concentrations of Parabens. J. Occup. Environ. Med.; 2017; 59, pp. 1034-1040. [DOI: https://dx.doi.org/10.1097/JOM.0000000000001106]
43. Samarasinghe, S.V.A.C.; Krishnan, K.; Naidu, R.; Megharaj, M.; Miller, K.; Fraser, B.; Aitken, R.J. Parabens generate reactive oxygen species in human spermatozoa. Andrology; 2018; 6, pp. 532-541. [DOI: https://dx.doi.org/10.1111/andr.12499]
44. Jurewicz, J.; Radwan, M.; Wielgomas, B.; Klimowska, A.; Kałużny, P.; Radwan, P.; Jakubowski, L.; Hanke, W. Environmental exposure to parabens and sperm chromosome disomy. Int. J. Environ. Health Res.; 2017; 27, pp. 332-343. [DOI: https://dx.doi.org/10.1080/09603123.2017.1339784]
45. Fransway, A.F.; Fransway, P.J.; Belsito, D.V.; Yiannias, J.A. Paraben Toxicology. Dermatitis; 2019; 30, pp. 32-45. [DOI: https://dx.doi.org/10.1097/DER.0000000000000428]
46. Axelsson, J.; Rylander, L.; Rignell-Hydbom, A.; Lindh, C.H.; Jönsson, B.A.; Giwercman, A. Prenatal phthalate exposure and reproductive function in young men. Environ. Res.; 2015; 138, pp. 264-270. [DOI: https://dx.doi.org/10.1016/j.envres.2015.02.024]
47. Hauser, R.; Skakkebaek, N.E.; Hass, U.; Toppari, J.; Juul, A.; Andersson, A.M.; Kortenkamp, A.; Heindel, J.J.; Trasande, L. Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union. J. Clin. Endocrinol. Metab.; 2015; 100, pp. 1267-1277. [DOI: https://dx.doi.org/10.1210/jc.2014-4325]
48. Stukenborg, J.B.; Mitchell, R.T.; Söder, O. Endocrine disruptors and the male reproductive system. Best Pract. Res. Clin. Endocrinol. Metab.; 2021; 35, 101567. [DOI: https://dx.doi.org/10.1016/j.beem.2021.101567]
49. Wu, Y.; Wang, J.; Wei, Y.; Chen, J.; Kang, L.; Long, C.; Wu, S.; Shen, L.; Wei, G. Contribution of prenatal endocrine-disrupting chemical exposure to genital anomalies in males: The pooled results from current evidence. Chemosphere; 2022; 286, 131844. [DOI: https://dx.doi.org/10.1016/j.chemosphere.2021.131844]
50. Page, M.J.; Mckenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaf, J.L.; Akl, E.A.; Brennan, S.E. et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Syst. Rev.; 2021; 10, 89. [DOI: https://dx.doi.org/10.1186/s13643-021-01626-4]
51. Meeker, J.D.; Ehrlich, S.; Toth, T.L.; Wright, D.L.; Calafat, A.M.; Trisini, A.T.; Ye, X.; Hauser, R. Semen quality and sperm DNA damage in relation to urinary bisphenol A among men from an infertility clinic. Reprod. Toxicol.; 2010; 30, pp. 532-539. [DOI: https://dx.doi.org/10.1016/j.reprotox.2010.07.005]
52. Lassen, T.H.; Frederiksen, H.; Jensen, T.K.; Petersen, J.H.; Joensen, U.N.; Main, K.M.; Skakkebaek, N.E.; Juul, A.; Jørgensen, N.; Andersson, A.M. Urinary bisphenol A levels in young men: Association with reproductive hormones and semen quality. Environ. Health Perspect.; 2014; 122, pp. 478-484. [DOI: https://dx.doi.org/10.1289/ehp.1307309]
53. Vitku, J.; Heracek, J.; Sosvorova, L.; Hampl, R.; Chlupacova, T.; Hill, M.; Sobotka, V.; Bicikova, M.; Starka, L. Associations of bisphenol A and polychlorinated biphenyls with spermatogenesis and steroidogenesis in two biological fluids from men attending an infertility clinic. Environ. Int.; 2016; 89–90, pp. 166-173. [DOI: https://dx.doi.org/10.1016/j.envint.2016.01.021]
54. Hu, W.; Dong, T.; Wang, L.; Guan, Q.; Song, L.; Chen, D.; Zhou, Z.; Chen, M.; Xia, Y.; Wang, X. Obesity aggravates toxic effect of BPA on spermatogenesis. Environ. Int.; 2017; 105, pp. 56-65. [DOI: https://dx.doi.org/10.1016/j.envint.2017.04.014]
55. Omran, G.A.; Gaber, H.D.; Mostafa, N.A.M.; Abdel-Gaber, R.M.; Salah, E.A. Potential hazards of bisphenol A exposure to semen quality and sperm DNA integrity among infertile men. Reprod. Toxicol.; 2018; 81, pp. 188-195. [DOI: https://dx.doi.org/10.1016/j.reprotox.2018.08.010]
56. Adoamnei, E.; Mendiola, J.; Vela-Soria, F.; Fernández, M.F.; Olea, N.; Jørgensen, N.; Swan, S.H.; Torres-Cantero, A.M. Urinary bisphenol A concentrations are associated with reproductive parameters in young men. Environ. Res.; 2018; 161, pp. 122-128. [DOI: https://dx.doi.org/10.1016/j.envres.2017.11.002]
57. Caporossi, L.; Alteri, A.; Campo, G.; Paci, E.; Tranfo, G.; Capanna, S.; Papaleo, E.; Pigini, D.; Viganò, P.; Papaleo, B. Cross Sectional Study on Exposure to BPA and Phthalates and Semen Parameters in Men Attending a Fertility Center. Int. J. Environ. Res. Public Health; 2020; 17, 489. [DOI: https://dx.doi.org/10.3390/ijerph17020489]
58. Palak, E.; Lebiedzińska, W.; Anisimowicz, S.; Sztachelska, M.; Pierzyński, P.; Wiczkowski, W.; Żelazowska-Rutkowska, B.; Niklińska, G.N.; Ponikwicka-Tyszko, D.; Wołczyński, S. The Association between Bisphenol A, Steroid Hormones, and Selected MicroRNAs Levels in Seminal Plasma of Men with Infertility. J. Clin. Med.; 2021; 10, 5945. [DOI: https://dx.doi.org/10.3390/jcm10245945]
59. Benson, T.E.; Gaml-Sørensen, A.; Ernst, A.; Brix, N.; Hougaard, K.S.; Hærvig, K.K.; Ellekilde Bonde, J.P.; Tøttenborg, S.S.; Lindh, C.H.; Ramlau-Hansen, C.H. et al. Urinary Bisphenol A, F and S Levels and Semen Quality in Young Adult Danish Men. Int. J. Environ. Res. Public Health; 2021; 18, 1742. [DOI: https://dx.doi.org/10.3390/ijerph18041742]
60. Chen, P.P.; Liu, C.; Zhang, M.; Miao, Y.; Cui, F.P.; Deng, Y.L.; Luo, Q.; Zeng, J.Y.; Shi, T.; Lu, T.T. et al. Associations between urinary bisphenol A and its analogues and semen quality: A cross-sectional study among Chinese men from an infertility clinic. Environ. Int.; 2022; 161, 107132. [DOI: https://dx.doi.org/10.1016/j.envint.2022.107132]
61. Duty, S.M.; Singh, N.P.; Silva, M.J.; Barr, D.B.; Brock, J.W.; Ryan, L.; Herrick, R.F.; Christiani, D.C.; Hauser, R. The relationship between environmental exposures to phthalates and DNA damage in human sperm using the neutral comet assay. Environ. Health Perspect.; 2003; 111, pp. 1164-1169. [DOI: https://dx.doi.org/10.1289/ehp.5756] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12842768]
62. Hauser, R.; Meeker, J.D.; Duty, S.; Silva, M.J.; Calafat, A.M. Altered semen quality in relation to urinary concentrations of phthalate monoester and oxidative metabolites. Epidemiology; 2006; 17, pp. 682-691. [DOI: https://dx.doi.org/10.1097/01.ede.0000235996.89953.d7] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17003688]
63. Liu, L.; Bao, H.; Liu, F.; Zhang, J.; Shen, H. Phthalates exposure of Chinese reproductive age couples and its effect on male semen quality, a primary study. Environ. Int.; 2012; 42, pp. 78-83. [DOI: https://dx.doi.org/10.1016/j.envint.2011.04.005] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21524797]
64. Jurewicz, J.; Radwan, M.; Sobala, W.; Ligocka, D.; Radwan, P.; Bochenek, M.; Hawuła, W.; Jakubowski, L.; Hanke, W. Human urinary phthalate metabolites level and main semen parameters, sperm chromatin structure, sperm aneuploidy and reproductive hormones. Reprod. Toxicol.; 2013; 42, pp. 232-241. [DOI: https://dx.doi.org/10.1016/j.reprotox.2013.10.001] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24140385]
65. Axelsson, J.; Rylander, L.; Rignell-Hydbom, A.; Jönsson, B.A.; Lindh, C.H.; Giwercman, A. Phthalate exposure and reproductive parameters in young men from the general Swedish population. Environ. Int.; 2015; 85, pp. 54-60. [DOI: https://dx.doi.org/10.1016/j.envint.2015.07.005]
66. Bloom, M.S.; Whitcomb, B.W.; Chen, Z.; Ye, A.; Kannan, K.; Buck Louis, G.M. Associations between urinary phthalate concentrations and semen quality parameters in a general population. Hum. Reprod.; 2015; 30, pp. 2645-2657. [DOI: https://dx.doi.org/10.1093/humrep/dev219]
67. Wang, Y.X.; You, L.; Zeng, Q.; Sun, Y.; Huang, Y.H.; Wang, C.; Wang, P.; Cao, W.C.; Yang, P.; Li, Y.F. et al. Phthalate exposure and human semen quality: Results from an infertility clinic in China. Environ. Res.; 2015; 142, pp. 1-9. [DOI: https://dx.doi.org/10.1016/j.envres.2015.06.010]
68. Jurewicz, J.; Radwan, M.; Sobala, W.; Radwan, P.; Jakubowski, L.; Wielgomas, B.; Ligocka, D.; Brzeźnicki, S.; Hanke, W. Exposure to widespread environmental endocrine disrupting chemicals and human sperm sex ratio. Environ. Pollut.; 2016; 213, pp. 732-740. [DOI: https://dx.doi.org/10.1016/j.envpol.2016.02.008]
69. Thurston, S.W.; Mendiola, J.; Bellamy, A.R.; Levine, H.; Wang, C.; Sparks, A.; Redmon, J.B.; Drobnis, E.Z.; Swan, S.H. Phthalate exposure and semen quality in fertile US men. Andrology; 2016; 4, pp. 632-638. [DOI: https://dx.doi.org/10.1111/andr.12124]
70. Chen, Q.; Yang, H.; Zhou, N.; Sun, L.; Bao, H.; Tan, L.; Chen, H.; Ling, X.; Zhang, G.; Huang, L. et al. Phthalate exposure, even below US EPA reference doses, was associated with semen quality and reproductive hormones: Prospective MARHCS study in general population. Environ. Int.; 2017; 104, pp. 58-68. [DOI: https://dx.doi.org/10.1016/j.envint.2017.04.005]
71. Meeker, J.D.; Yang, T.; Ye, X.; Calafat, A.M.; Hauser, R. Urinary concentrations of parabens and serum hormone levels, semen quality parameters, and sperm DNA damage. Environ. Health Perspect.; 2011; 119, pp. 252-257. [DOI: https://dx.doi.org/10.1289/ehp.1002238]
72. Nishihama, Y.; Toshima, H.; Yoshinaga, J.; Mizumoto, Y.; Yoneyama, M.; Nakajima, D.; Shiraishi, H.; Tokuoka, S. Paraben exposure and semen quality of Japanese male partners of subfertile couples. Environ. Health Prev. Med.; 2017; 22, 5. [DOI: https://dx.doi.org/10.1186/s12199-017-0618-7]
73. Adoamnei, E.; Mendiola, J.; Moñino-García, M.; Vela-Soria, F.; Iribarne-Durán, L.M.; Fernández, M.F.; Olea, N.; Jørgensen, N.; Swan, S.H.; Torres-Cantero, A.M. Urinary concentrations of parabens and reproductive parameters in young men. Sci. Total Environ.; 2018; 621, pp. 201-209. [DOI: https://dx.doi.org/10.1016/j.scitotenv.2017.11.256]
74. Smarr, M.M.; Honda, M.; Kannan, K.; Chen, Z.; Kim, S.; Louis, G.M.B. Male urinary biomarkers of antimicrobial exposure and bi-directional associations with semen quality parameters. Reprod. Toxicol.; 2018; 77, pp. 103-108. [DOI: https://dx.doi.org/10.1016/j.reprotox.2018.02.008]
75. Ješeta, M.; Franzová, K.; Machynová, S.; Kalina, J.; Kohoutek, J.; Mekiňová, L.; Crha, I.; Kempisty, B.; Kašík, M.; Žáková, J. et al. The Bisphenols Found in the Ejaculate of Men Does Not Pass through the Testes. Toxics; 2022; 10, 311. [DOI: https://dx.doi.org/10.3390/toxics10060311] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/35736919]
76. Rahman, M.S.; Kwon, W.S.; Lee, J.S.; Yoon, S.J.; Ryu, B.Y.; Pang, M.G. Bisphenol-A affects male fertility via fertility-related proteins in spermatozoa. Sci. Rep.; 2015; 5, 9169. [DOI: https://dx.doi.org/10.1038/srep09169] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25772901]
77. Luconi, M.; Bonaccorsi, L.; Forti, G.; Baldi, E. Effects of estrogenic compounds on human spermatozoa: Evidence for interaction with a nongenomic receptor for estrogen on human sperm membrane. Mol. Cell Endocrinol.; 2001; 178, pp. 39-45. [DOI: https://dx.doi.org/10.1016/S0303-7207(01)00416-6]
78. Skibińska, I.; Jendraszak, M.; Borysiak, K.; Jędrzejczak, P.; Kotwicka, M. 17β-estradiol and xenoestrogens reveal synergistic effect on mitochondria of human sperm. Ginekol. Pol.; 2016; 87, pp. 360-366. [DOI: https://dx.doi.org/10.5603/GP.2016.0005]
79. Barbonetti, A.; Castellini, C.; Di Giammarco, N.; Santilli, G.; Francavilla, S.; Francavilla, F. In vitro exposure of human spermatozoa to bisphenol A induces pro-oxidative/apoptotic mitochondrial dysfunction. Reprod. Toxicol.; 2016; 66, pp. 61-67. [DOI: https://dx.doi.org/10.1016/j.reprotox.2016.09.014]
80. Grami, D.; Rtibi, K.; Selmi, S.; Jridi, M.; Sebai, H.; Marzouki, L.; Sabovic, I.; Foresta, C.; De Toni, L. Aqueous extract of Eruca Sativa protects human spermatozoa from mitochondrial failure due to bisphenol A exposure. Reprod. Toxicol.; 2018; 82, pp. 103-110. [DOI: https://dx.doi.org/10.1016/j.reprotox.2018.10.008]
81. Castellini, C.; Di Giammarco, N.; D’Andrea, S.; Parisi, A.; Totaro, M.; Francavilla, S.; Francavilla, F.; Barbonetti, A. Effects of bisphenol S and bisphenol F on human spermatozoa: An in vitro study. Reprod. Toxicol.; 2021; 103, pp. 58-63. [DOI: https://dx.doi.org/10.1016/j.reprotox.2021.05.011]
82. Sun, X.; Chen, W.; Weng, S.; Pan, T.; Hu, X.; Wang, F.; Xia, T.; Chen, H.; Luo, T. Effects of the environmental endocrine disruptors di-2-ethylhexyl phthalate and mono-2-ethylhexyl phthalate on human sperm function in vitro. Reprod. Fertil. Dev.; 2020; 32, pp. 629-636. [DOI: https://dx.doi.org/10.1071/RD19164]
83. Huffman, A.M.; Wu, H.; Rosati, A.; Rahil, T.; Sites, C.K.; Whitcomb, B.W.; Richard Pilsner, J. Associations of urinary phthalate metabolites and lipid peroxidation with sperm mitochondrial DNA copy number and deletions. Environ. Res.; 2018; 163, pp. 10-15. [DOI: https://dx.doi.org/10.1016/j.envres.2018.01.023]
84. Tavares, R.S.; Martins, F.C.; Oliveira, P.J.; Ramalho-Santos, J.; Peixoto, F.P. Parabens in male infertility-is there a mitochondrial connection?. Reprod. Toxicol.; 2009; 27, pp. 1-7. [DOI: https://dx.doi.org/10.1016/j.reprotox.2008.10.002]
85. Bennetts, L.E.; De Iuliis, G.N.; Nixon, B.; Kime, M.; Zelski, K.; McVicar, C.M.; Lewis, S.E.; Aitken, R.J. Impact of estrogenic compounds on DNA integrity in human spermatozoa: Evidence for cross-linking and redox cycling activities. Mutat. Res.; 2008; 641, pp. 1-11. [DOI: https://dx.doi.org/10.1016/j.mrfmmm.2008.02.002]
86. Mao, J.B.; Luo, S.H.; Luo, Y.; Yuan, B.; Li, Y.H.; Luo, P.C.; Miao, Y.L.; Wang, J.L. Content of seminal plasma plasticizer in the patients with idiopathic asthenozoospermia and its impact on male fertility. Zhonghua Nan Ke Xue; 2019; 25, pp. 1097-1101.
87. Sumner, R.N.; Tomlinson, M.; Craigon, J.; England, G.C.W.; Lea, R.G. Independent and combined effects of diethylhexyl phthalate and polychlorinated biphenyl 153 on sperm quality in the human and dog. Sci. Rep.; 2019; 9, 3409. [DOI: https://dx.doi.org/10.1038/s41598-019-39913-9]
88. Urriola-Muñoz, P.; Lagos-Cabré, R.; Moreno, R.D. A mechanism of male germ cell apoptosis induced by bisphenol-A and nonylphenol involving ADAM17 and p38 MAPK activation. PLoS ONE; 2014; 9, e113793. [DOI: https://dx.doi.org/10.1371/journal.pone.0113793]
89. Song, W.H.; Mohamed, E.A.; Pang, W.K.; Kang, K.H.; Ryu, D.Y.; Rahman, M.S.; Pang, M.G. Effect of endocrine disruptors on the ratio of X and Y chromosome-bearing live spermatozoa. Reprod. Toxicol.; 2018; 82, pp. 10-17. [DOI: https://dx.doi.org/10.1016/j.reprotox.2018.09.002]
90. Xiong, F.; Zhou, B.; Wu, N.X.; Deng, L.J.; Xie, J.Y.; Li, X.J.; Chen, Y.J.; Wang, Y.X.; Zeng, Q.; Yang, P. The Association of Certain Seminal Phthalate Metabolites on Spermatozoa Apoptosis: An Exploratory Mediation Analysis via Sperm Protamine. Environ. Pollut.; 2022; 300, 118969. [DOI: https://dx.doi.org/10.1016/j.envpol.2022.118969]
91. Marchiani, S.; Tamburrino, L.; Farnetani, G.; Muratori, M.; Vignozzi, L.; Baldi, E. Acute effects on human sperm exposed in vitro to cadmium chloride and diisobutyl phthalate. Reproduction; 2019; 158, pp. 281-290. [DOI: https://dx.doi.org/10.1530/REP-19-0207]
92. Yang, P.; Gong, Y.J.; Wang, Y.X.; Liang, X.X.; Liu, Q.; Liu, C.; Chen, Y.J.; Sun, L.; Lu, W.Q.; Zeng, Q. Effect modification by apoptosis-related gene polymorphisms on the associations of phthalate exposure with spermatozoa apoptosis and semen quality. Environ. Pollut.; 2017; 231, pp. 694-702. [DOI: https://dx.doi.org/10.1016/j.envpol.2017.08.034]
93. Li, D.; Yuan, D.; Zhang, L.; Qiao, P.; Liang, X.; Chang, B. Increase of apoptosis and decrease of sperm motility induced by oxidative stress after exposed to butyl p-hydroxybenzoate. Wei Sheng Yan Jiu; 2017; 46, pp. 196-200.
94. Miao, M.; Zhou, X.; Li, Y.; Zhang, O.; Zhou, Z.; Li, T.; Yuan, W.; Li, R.; Li, D.K. LINE-1 hypomethylation in spermatozoa is associated with Bisphenol A exposure. Andrology; 2014; 2, pp. 138-144. [DOI: https://dx.doi.org/10.1111/j.2047-2927.2013.00166.x]
95. Zheng, H.; Zhou, X.; Li, D.K.; Yang, F.; Pan, H.; Li, T.; Miao, M.; Li, R.; Yuan, W. Genome-wide alteration in DNA hydroxymethylation in the sperm from bisphenol A-exposed men. PLoS ONE; 2017; 12, e0178535. [DOI: https://dx.doi.org/10.1371/journal.pone.0178535]
96. Song, X.; Miao, M.; Zhou, X.; Li, D.; Tian, Y.; Liang, H.; Li, R.; Yuan, W. Bisphenol A Exposure and Sperm ACHE Hydroxymethylation in Men. Int. J. Environ. Res. Public Health; 2019; 16, 152. [DOI: https://dx.doi.org/10.3390/ijerph16010152]
97. Wu, H.; Estill, M.S.; Shershebnev, A.; Suvorov, A.; Krawetz, S.A.; Whitcomb, B.W.; Dinnie, H.; Rahil, T.; Sites, C.K.; Pilsner, J.R. Preconception urinary phthalate concentrations and sperm DNA methylation profiles among men undergoing IVF treatment: A cross-sectional study. Hum. Reprod.; 2017; 32, pp. 2159-2169. [DOI: https://dx.doi.org/10.1093/humrep/dex283]
98. Wu, H.; Ashcraft, L.; Whitcomb, B.W.; Rahil, T.; Tougias, E.; Sites, C.K.; Pilsner, J.R. Parental contributions to early embryo development: Influences of urinary phthalate and phthalate alternatives among couples undergoing IVF treatment. Hum. Reprod.; 2017; 32, pp. 65-75. [DOI: https://dx.doi.org/10.1093/humrep/dew301]
99. Tian, M.; Liu, L.; Zhang, J.; Huang, Q.; Shen, H. Positive association of low-level environmental phthalate exposure with sperm motility was mediated by DNA methylation: A pilot study. Chemosphere; 2019; 220, pp. 459-467. [DOI: https://dx.doi.org/10.1016/j.chemosphere.2018.12.155]
100. Bisconti, M.; Simon, J.F.; Grassi, S.; Leroy, B.; Martinet, B.; Arcolia, V.; Isachenko, V.; Hennebert, E. Influence of Risk Factors for Male Infertility on Sperm Protein Composition. Int. J. Mol. Sci.; 2021; 22, 13164. [DOI: https://dx.doi.org/10.3390/ijms222313164]
101. Imamovic Kumalic, S.; Pinter, B. Review of clinical trials on effects of oral antioxidants on basic semen and other parameters in idiopathic oligoasthenoteratozoospermia. Biomed. Res. Int.; 2014; 14, 426951. [DOI: https://dx.doi.org/10.1155/2014/426951]
102. Imamovic Kumalic, S.; Virant Klun, I.; Vrtacnik Bokal, E.; Pinter, B. Effect of the oral intake of astaxanthin on semen parameters in patients with oligo-astheno-teratozoospermia: A randomized double-blind placebo-controlled trial. Radiol. Oncol.; 2020; 55, pp. 97-105. [DOI: https://dx.doi.org/10.2478/raon-2020-0062]
103. De Ligny, W.; Smits, R.M.; Mackenzie-Proctor, R.; Jordan, V.; Fleischer, K.; de Bruin, J.P.; Showell, M.G. Antioxidants for male subfertility. Cochrane Database Syst. Rev.; 2022; 5, CD007411. [DOI: https://dx.doi.org/10.1002/14651858.CD007411.pub]
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Details
1 Clinical Research Centre, University Medical Centre Ljubljana, Vrazov Trg 1, 1000 Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Vrazov Trg 2, 1000 Ljubljana, Slovenia
2 Faculty of Medicine, University of Ljubljana, Vrazov Trg 2, 1000 Ljubljana, Slovenia; Division of Obstetrics and Gynecology, University Medical Centre Ljubljana, Slajmerjeva 3, 1000 Ljubljana, Slovenia